Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Zielgerichtete Therapie des NSCLC mit Gefitinib in Abhängigkeit von der Art der EGFR-Mutation: Auswertung der klinischen Wirksamkeit in REASON Exon-Subgruppen.

Schuette, W., Eberhardt, W., Schirmacher, P., Dietel, M., Zirrgiebel, U., Radke, S., Thomas, M., 2016.

Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin P429.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGP / Journal: -
REASON
2016
REASON: Factors influencing outcome in patients (pts) with NSCLC stage IIIB/IV and mutated EGF receptor (EGFR-M+) treated with gefitinib.

Schuette, W., Eberhardt, W., Schirmacher, P., Dietel, M., Zirrgiebel, U., Radke, S., Thomas, M., 2016.

Oncol Res Treat, 39 (suppl 1) (ID 0345), 120. doi:10.1159/000444354

Abstract

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DKK / Journal: Oncology Research and Treatment
REASON
2016
Clinical Outcome of Targeted Therapy with Gefitinib in Metastatic NSCLC Depending on the Type of EGFR Mutation: A REASON Subgroup Analysis by Exon.

Schuette, W., Dietel, M., Thomas, M., Eberhardt, W., Zirrgiebel, U., Radke, S., Schirmacher, P., 2016.

Oncol Res Treat, 39 (suppl 1), (ID 0341) 120. doi:10.1159/000444354

Abstract

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DKK / Journal: Oncology Research and Treatment
REASON
2016
Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial.

Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H.-J., Hinke, A., Al-Batran, S.-E., Arnold, D., 2016.

Ann Oncol 27(6), 149–206, 557P. doi:10.1093/annonc/mdw370.105

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
AIO KRK 0207
2016
Quality of Life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: A preplanned analysis of the phase III AIO KRK 0207 trial.

Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C.A., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H.-J., Hinke, A., Al-Batran, S.-E., Arnold, D., 2016.

Ann Oncol 27, 2203–2210. doi:10.1093/annonc/mdw425

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: Annals of Oncology
AIO KRK 0207
2016
Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: Final results of the non-interventional study NABUCCO.

Potthoff, K., Nusch, A., Söling, U., Hansen, R., Salat, Grebhardt, S., Marschner, N., 2016.

Ann Oncol (2016) 27 (suppl_6): 236P. doi:10.1093/annonc/mdw365.15

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
NABUCCO
2016
Impact of age on the safety and efficacy of bevacizumab (BEV)-containing therapy in patients (pts) with primary ovarian cancer (OC): Analyses from the OTILIA German non-interventional study on behalf of the North-Eastern German Society of Gynaecological Oncology (NOGGO) Ovarian Cancer Working Group.

Mustea, A., Wimberger, P., Oskay-Oezcelik, G., Jungberg, P., Meinerz, W., Reichert, D., Janssen, J., Keller, M., Richter, R., Harde, J., Klawitter, S., Wegenaer, A., Mueller, M., Sehouli, J., 2016.

Ann Oncol 27(suppl_6), 296–312, 867P. doi:10.1093/annonc/mdw374.14

Abstract

Indikation: Other, Sonstige / Veranstaltung: ESMO / Journal: Annals of Oncology
OTILIA
2016
Survival of Patients With Advanced or Metastatic Renal Cell Carcinoma in Routine Practice Differs From That in Clinical Trials-Analyses From the German Clinical RCC Registry.

Marschner, N., Staehler, M., Müller, L., Nusch, A., Harde, J., Koska, M., Jänicke, M., Goebell, P.J., RCC Registry Group, 2016.

Clin Genitourin Cancer. Clin Genitourin Cancer 15(2), e209–e215. doi:10.1016/j.clgc.2016.08.022

Abstract

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: - / Journal: Clinical Genitourinary Cancer
TNK
2016
Wechselnde Symptombelastung – gleichbleibende Lebensqualität? – Longitudinale Daten des MaLife-Projekts zu Patientinnen mit metastasiertem Mammakarzinom unter Monochemo- bzw. Hormontherapie.

Marschner, N., Nusch, A., Decker, T., Münz, M., Kruggel, L., Jänicke, M., 2016.

Senologie – Zeitschrift für Mammadiagnostik und -therapie 02, P074. doi:10.1055/s-0036-1583404

Abstract
Download

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: Senologie Kongress / Journal: Senologie
TMK
2016
Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with breast cancer: results from an interim analysis of the non-interventional study NADIR.

Kurbacher, C., Fietz, T., Trarbach, T., Salat, C., Rezai, M., Lorenz, A., Niemeier, B., 2016.

Ann Oncol (2016) 27 (suppl_6): 1457P. doi:10.1093/annonc/mdw390.25

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ESMO / Journal: Annals of Oncology
NADIR
2016